Roctavian™ (valoctocogene roxaparvovec-rvox)
| Full Name | Roctavian™ (valoctocogene roxaparvovec-rvox) |
| Drug | Roctavian |
| Manufacturer | BioMarin Pharmaceutical Inc. |
| Route of Administration | Intravenous |
| Site of Care | Healthcare Facility |
| Approved Indication | The treatment of adults with severe hemophilia A (congenital factor VIII deficiency with factor VIII activity < 1 IU/dL) without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test |
| Disease | Hemophilia A |
| Therapeutic Area | Hematology; Cell & Gene Therapy |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-358-0013 |
| Fax Number | 877-631-9228 |
| Product Website | roctavian.com |